Home » Topics » BioWorld Science

BioWorld Science
RSS

BMS's ACE/NEP inhibitors in phase I

April 26, 1996

New Glaxo Wellcome compounds protect against leukocyte-induced tissue damage

April 26, 1996

TAC-363 pharmacological profile presented

April 26, 1996

Merck Frosst's new generation of 5-LO inhibitors

April 26, 1996

Taisho's erythromycin A derivatives suppress IL-5 production

April 26, 1996

New antiasthmatic drugs patented by Fujirebio

April 26, 1996

Nikken Chemicals claims new antiasthmatic compounds

April 26, 1996

Promising clinical results reported for CRF

April 26, 1996

Update on terfenadine carboxylate progress

April 26, 1996

NMDA/glycine-site antagonists revealed by RPR

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...